U.S. markets closed
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • Dow 30

    35,294.76
    +382.20 (+1.09%)
     
  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     
  • Russell 2000

    2,265.65
    -8.52 (-0.37%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Silver

    23.35
    -0.13 (-0.54%)
     
  • EUR/USD

    1.1606
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • GBP/USD

    1.3751
    +0.0074 (+0.54%)
     
  • USD/JPY

    114.2000
    +0.5230 (+0.46%)
     
  • BTC-USD

    61,507.58
    +2,171.73 (+3.66%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

Activist investor Trian trims P&G, Mondelez stakes

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK (Reuters) - Activist investment firm Trian Fund Management LP has trimmed its stake in two consumer staples companies, Procter & Gamble Co and snack foods company Mondelez International Inc, according to regulatory filings.

Trian, founded by Nelson Peltz, Ed Garden and Peter May, held 8.9 million shares in P&G at the end of the first quarter, down 9.6% from the 9.8 million shares it owned at the end of the fourth quarter, according to a regulatory filing.

Peltz joined the P&G board in 2018 after a bitter proxy contest.

The firm also cut its stake in Mondelez by 23% to hold 9.4 million shares.

The so-called 13F filings show what fund managers owned at the end of the first quarter and while they are backward-looking, they are closely watched for clues on trends and what stocks certain fund managers are favoring.

New York-based Trian is known for proposing operational fixes at its portfolio companies, often through white papers. The activist firm presents itself as a partner that can offer constructive advice rather than the corporate raider intent on breaking companies apart.

(Reporting by Megan Davies in New York and Svea Herbst-Bayliss in Boston; Editing by Matthew Lewis)